) mouse remained resistant to MBP in active EAE induction, the disease severity was uniformly higher in MOG-induced active EAE and in MBP-induced adoptive EAE when compared to those of B6 (H-2 b ) mice. Treatment of mice with anti-CD25 antibodies prior to immunization caused 60% of SJL.B mice to become susceptible to MBP-induced EAE while only 14% of B6 mice were converted. In addition, MOG-induced EAE in SJL.B mice followed a remitting-relapsing disease course while B6 mice only exhibited monophasic or chronic episodes. The new SJL.B mouse strain provides a valuable tool for studying EAE resistance and remitting-relapsing disease in H-2 b mice.
Introduction
Experimental autoimmune encephalomyelitis (EAE) is an autoimmune disease of the central nervous system (CNS) and has been used as an animal model for study of the human demyelinating disease, multiple sclerosis (MS). EAE is characterized by pathologic infiltration of mononuclear cells into the CNS and by clinical manifestation of paralytic symptoms (Raine, 1984) . EAE can be induced in animals by immunization with myelin antigens or by adoptive transfer of myelin antigen-primed donor T cells into naïve recipients (Traugott et al., 1985 (Traugott et al., , 1986 . Three major myelin antigens are commonly used, namely, myelin basic protein (MBP) (Zamvil et al., 1986) , proteolipid protein (PLP) (Trotter et al., 1987; Tuohy et al., 1989) and myelin oligodentrocyte glycoprotein (MOG) (Johns et al., 1995) . For EAE induced by MBP and PLP, SJL is a highly susceptible mouse strain that is often used as a prototype of this disease model. After developing an acute phase of the disease, these mice spontaneously undergo remission. However, these mice are also prone to spontaneous disease relapses and the remitting/relapsing cycles become a recurring feature of the disease (Kim and Tse, 1993) . In contrast to SJL mice, C57BL/6 mice (B6) exhibit no disease symptoms when immunized with MBP with the same exact experimental procedures (Levine and Sowinski, 1974; Bernard, 1976; Shaw et al., 1992) . These mice are loosely referred to as EAE resistant, although the basis of this unresponsiveness/resistance is not fully understood. The genes that control EAE susceptibility have been mapped to the H-2 complex (Fritz et al., 1985; Butterfield et al., 1998) , but non-H-2 background genes are also implicated (Montgomery and Rauch, 1982; Linthicum and Frelinger, 1982; Butterfield et al., 1998) . B10.S mice, for example, share with SJL mice the same H-2 s haplotype but are resistant to EAE induction with MBP or PLP (Korngold et al., 1986; Shaw et al., 1992; Encinas et al., 1996; Butterfield et al., 1998) . The SJL genetic background, as opposed to that of the C57BL/10 (B10), apparently has influenced the level of MBP-specific encephalitogenicity in the H-2 s mice. How would the SJL genetic background modify the MBPinduced disease development in EAE resistant H-2 b mice is the subject of this report. Previously, Shaw et al. (1992) showed that EAE resistance was not simply a lack of phenotypic responsiveness, but was an actively regulated process. These investigators found that while adoptive transfer of MBP-sensitized B6 donor lymph node cells into syngeneic naïve recipients failed to generate disease, subsequent challenge of the recipients with MBP emulsified in CFA (MBP-CFA) induced severe symptoms of EAE very similar to those induced in susceptible strains with adoptive transfer alone. These experiments clearly establish the important concept that MBP-specific encephalitogenic T cells exist in resistant H-2 b mice and that the lack of detectable EAE responses is mediated by other mechanisms perhaps Journal of Neuroimmunology 234 (2011) 109-114 
